SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-13-177665
Filing Date
2013-04-26
Accepted
2013-04-26 16:05:37
Documents
9
Period of Report
2013-06-06
Effectiveness Date
2013-04-26

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d499301ddef14a.htm DEF 14A 690439
2 GRAPHIC g499301g07o10.jpg GRAPHIC 9013
3 GRAPHIC g499301pc001a.jpg GRAPHIC 39397
4 GRAPHIC g499301pc001b.jpg GRAPHIC 36697
5 GRAPHIC g499301pc001c.jpg GRAPHIC 4187
6 GRAPHIC g499301pc001d.jpg GRAPHIC 15374
7 GRAPHIC g499301pc001e.jpg GRAPHIC 34644
8 GRAPHIC g499301sig_001.jpg GRAPHIC 5970
9 GRAPHIC g499301sig_002.jpg GRAPHIC 8520
  Complete submission text file 0001193125-13-177665.txt   904652
Mailing Address 320 BENT STREET CAMBRIDGE MA 02141
Business Address 320 BENT STREET CAMBRIDGE MA 02141 617-995-9800
IDENIX PHARMACEUTICALS INC (Filer) CIK: 0001093649 (see all company filings)

IRS No.: 450478605 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-49839 | Film No.: 13787423
SIC: 2834 Pharmaceutical Preparations